| Literature DB >> 26970785 |
Petja Marinova, Marin Marinov, Maria Kazakova, Yana Feodorova, Alexander Slavchev, Denica Blazheva, Danail Georgiev, Plamen Penchev, Victoria Sarafian, Neyko Stoyanov.
Abstract
This work describes a method for synthesis, as well as in vitro antiproliferative and antibacterial investigation of 3-methyl-9'-fluorenespiro-5-hydantoin. The structure of the substituted fluorenylspirohydantoin derivative was verified by UV-Vis, FT-IR, Raman, (1)H-NMR and (13)C-NMR spectroscopy, and by using a combination of 2D NMR experiments, which included (1)H-(1)H COSY, HMQC and HMBC sequences. The geometry of the compound was optimized by the B3LYP density functional with 6-31G(d) basis set and the (1)H and (13)C NMR spectra were predicted with the HF/6-31G(d) calculations at the optimized geometry. The anticancer activity of the 3-methyl-9'-fluorenespiro-5-hydantoin was determined in suspension cell lines originating from tumors in humans (WERI-Rb-1). The cytotoxic effect was evaluated by WST-assay (Roche Applied Science). The antimicrobial effect of the compound against Gram-negative, Gram-positive bacteria and the yeast Candida albicans was investigated.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26970785 DOI: 10.17344/acsi.2015.1591
Source DB: PubMed Journal: Acta Chim Slov ISSN: 1318-0207 Impact factor: 1.735